1 Min Read
April 3 (Reuters) - Roche Holding Ag
* Says phase iii alur study supports the use of alecensa for people with advanced alk-positive lung cancer Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.